Bioadhesion of solid oral dosage forms, why and how?

Author： Duchene D.   Ponchel G.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.44, Iss.1, 1997-07, pp. : 15-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms

By  

Current Pharmaceutical Design, Vol. 21, Iss. 40, 2015-12 ,pp. : 5854-5867

Bentham Science Publishers

Access to resources Recommend Favorite

Bioavailability of valsartan oral dosage forms

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 132-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?

By Ohrem H. Leonhard   Schornick Eva   Kalivoda Adela   Ognibene Roberto  

Pharmaceutical Development and Technology, Vol. 19, Iss. 3, 2014-05 ,pp. : 257-262

Informa Healthcare

Access to resources Recommend Favorite

Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies

By Missaghi Shahrzad   Young Cara   Fegely Kurt   Rajabi-Siahboomi Ali R.  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 2, 2010-01 ,pp. : 180-189

Informa Healthcare

Access to resources Recommend Favorite

A Review of: “Generic Drug Product Development – Solid Oral Dosage Forms, Drugs and the Pharmaceutical Sciences # 143”

By Brittain Harry  

Pharmaceutical Development and Technology, Vol. 11, Iss. 3, 2006-09 ,pp. : 399-399

Informa Healthcare

Access to resources Recommend Favorite